Afya Ltd

Afya Ltd. is a medical education group, which engages in the provision of an end-to-end physician-centric ecosystem that serves and empowers students to be lifelong medical learners through their medical residency preparation, post-graduate programs, and continuing medical education activities. It operates through Education Services; and Digital Content, Residency Preparatory and Specialization Programs segments. The Education Services segment provides educational services through undergraduate and graduate courses related to medicine, other health sciences, and other undergraduate programs. The Residency Preparatory and Specialization Programs segment offers digital and printed medical content services, including online courses for residency preparatory, medical and other than medical post-graduate specialization programs and mobile app subscription for digital medical content. The company was founded on March 22, 2019 and is headquartered in Nova Lima, Brazil.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Afya Ltd excels in Q2 2024 earnings, eyes growth opportunities

Afya Ltd delivered a robust performance in Q2 2024, marked by significant growth in key financial metrics, student base expansion, and strategic acquisitions.
The company's strengths lie in its strong financial position, updated guidance, operational insights, and engagement with analysts on critical industry topics.
Challenges include maintaining margins, integrating acquisitions, managing growth effectively, and adapting to potential regulatory shifts in the sector.
Opportunities for Afya include leveraging growth trends, strategic partnerships, innovation, and operational excellence to drive sustainable value creation and market leadership.

Afya Ltd reports strong Q3 earnings and eyes sustainable growth

Afya Ltd delivered a robust performance in Q3 2024, with notable revenue and EBITDA growth, demonstrating operational efficiency and financial resilience.
Despite facing challenges in a competitive landscape, the company's strategic acquisitions and focus on operational metrics provide a solid foundation for future growth.
With a strong balance sheet, improved margins, and a focus on sustainable expansion, Afya Ltd is well-positioned to capitalize on opportunities in the healthcare education sector.
Investors should monitor Afya Ltd's execution of growth strategies, operational performance, and ability to navigate challenges to assess its long-term value creation potential.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Afya (AFYA) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.28 per share a year ago.

Afya (AFYA) Q3 Earnings Miss Estimates

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three and nine-month periods ended September 30, 2024 (third quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Third Quarter 2024 Highlights 3Q24 Net.

Afya Limited Third Quarter and Nine Months 2024 Financial Results

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced today that it will report third-quarter and nine months 2024 financial results for the period ended September 30th, 2024, following the close of the market on Wednesday, November 13th, 2024 and will host a corresponding conference call and webcast at 05:00 pm EST. A live and archived webcast of the.

Afya Limited to Report Third Quarter and Nine Months 2024 Financial Results on November 13th

Investors need to pay close attention to AFYA stock based on the movements in the options market lately.

Is the Options Market Predicting a Spike in AFYA Stock?

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that it will host its Afya Day on October 29th, 2024. The event will be held in a hybrid format, combining both in-person and online participation, and will feature presentations from Afya's executive team, covering the Company's growth, business strategy and future outlook. Event Details: Da.

Afya Limited to Host Afya Day 2024 on October 29th | Hybrid Event

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, announced a public commitment to achieve 5 million free health consultations by 2030, in line with Sustainable Development Goal 3 (SDG 3), which aims to ensure healthy lives and promote well-being for all people, at all ages. To serve the communities and achieve the estimated results, Afya intends to increas.

Afya Assumes a Voluntary Commitment to Free Health Consultations

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that following the conclusion of an administrative procedure, the Ministry of Education (“MEC”), has granted the request for reconsideration submitted by Universidade do Grande Rio Professor José de Souza Herdy (“Unigranrio”). Per the e-MEC portal, Unigranrio reestablished 10 medical seats in.

Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced today that its wholly-owned subsidiary, Afya Participações S.A., has received the total disbursement of BRL500.0 million under the loan agreement with International Finance Corporation ("IFC") to support the Company's expansion program. The financing is IFC's first sustainability-linked loan based o.

Afya Secures Full Disbursement of R$500 Million From IFC to Support the Company's Expansion

Afya's Q2 2024 results showed stable operations with 14% revenue growth, driven by increased enrollment and tuition, and improved operating margins. A favorable Supreme Court ruling on medical seat openings and new financing from the IFC are positive developments for Afya. Despite short-term stability, long-term concerns arise due to potential oversupply in Brazil's medical education and profession markets.

Afya: Q2 2024 Was Not Surprising, Still An Opportunity Despite New Info On Market Supply

Afya (AFYA) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.29 per share a year ago.

Afya (AFYA) Surpasses Q2 Earnings and Revenue Estimates

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today financial and operating results for the three and six-month period, which ended on June 30, 2024 (second quarter 2024). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards (IFRS). Second Quarter 2024 Highlights 2Q2.

Afya Limited Announces Second-Quarter and First-Half 2024 Financial Results

Afya Limited (NASDAQ:AFYA ) Q2 2024 Earnings Conference Call August 14, 2024 5:00 PM ET Corporate Participants Renata Couto - Investor Relations Virgilio Gibbon - Chief Executive Officer Luis Andre Blanco - Chief Financial Officer Conference Call Participants Mirela Oliveira – Bank of America Lucca Marquezini - Itau Leandro Bastos - Citi Marcelo Santos - JPMorgan Mauricio Cepeda - Morgan Stanley Renata Couto Thank you for joining us for Afya's Conference Call. I'm here today with Afya's CEO, Virgilio Gibbon, and our CFO, Luis Andre Blanco.

Afya Limited (AFYA) Q2 2024 Earnings Call Transcript

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil announced today that its wholly-owned subsidiary, Afya Participações S.A., entered into a loan agreement with International Finance Corporation ("IFC") to finance its expansion program, through acquisitions. The financing is IFC's first sustainability-linked loan based on social targets in the education secto.

Afya Secures Loan of up to R$500 Million From IFC to Support the Company's Expansion

Pinduoduo Inc - ADR

Pilgrim's Pride

PPC, AFYA and PDD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 6, 2024.

Best Growth Stocks to Buy for August 6th

EverBank Financial

KB Home

Sprouts Farmers Markets

EVER, PPC, SFM, KBH and AFYA have been added to the Zacks Rank #1 (Strong Buy) List on August 6, 2024.

New Strong Buy Stocks for August 6th

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34), the leading medical education group and medical practice solutions provider in Brazil, announces the release of its 2023 Sustainability Report. The document, which presents Afya's trajectory throughout 2023, follows the Global Reporting Initiative (GRI) standards and is aligned with the Sustainable Development Goals (SDGs). It also reports specific indicators from the Sustainability Accounting Standards Board (SASB) an.

Afya Limited Releases 2023 Sustainability Report

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Afya (AFYA) Stock Undervalued Right Now?

Afya (AFYA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

What Makes Afya (AFYA) a New Strong Buy Stock

Bright Horizons Family Solutions

Investors interested in Schools stocks are likely familiar with Afya (AFYA) and Bright Horizons Family Solutions (BFAM). But which of these two stocks is more attractive to value investors?

AFYA vs. BFAM: Which Stock Is the Better Value Option?

Daktronics

Despegar.com

AFYA, DAKT and DESP made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 18, 2024.

Best Growth Stocks to Buy for July 18th

Atlantica Sustainable Infrastructure

Bank7 Corp

Suncor Energy

Telefonica SA

AY, TEF, AFYA, BSVN and SU have been added to the Zacks Rank #1 (Strong Buy) List on July 18, 2024.

New Strong Buy Stocks for July 18th

Sasol

AFYA SSL and PDD made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 16, 2024.

Best Growth Stocks to Buy for July 16th

Apogee Enterprises

Azenta

B2Gold

Kinross Gold

BTG, APOG, AZTA, AFYA and KGC have been added to the Zacks Rank #1 (Strong Buy) List on July 16, 2024.

New Strong Buy Stocks for July 16th

AFYA boosts its medical education service offerings in Brazil with an additional 80 seats at UNIMA Alagoas.

AFYA's Medical Seats Increase to 220 at UNIMA Alagoas in Brazil

NOVA LIMA, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (“MEC”) authorized the increase of 80 medical seats of Centro Universitário de Maceió (UNIMA Alagoas), in the city of Maceió, located in the state of Alagoas, which will result in an additional p.

News for Afya Ltd Stock (AFYA)